Lung Cancer
Innovative Treatment Options in Cuba

What is Lung Cancer?

Lung cancer is characterized by the uncontrolled proliferation of lung cells and accounts for approximately 12.5% of all cancers worldwide, making it the most prevalent cancer type.

How Does Lung Cancer Develop?

Chemical compounds inhaled into the lungs cause damage to lung tissues, resulting in DNA mutations. These mutations disrupt normal cell growth and division, leading to tumor formation and potentially metastasis.

What Causes Lung Cancer? Who is at Higher Risk?

The leading cause is smoking—80–90% of cases involve tobacco use. Other risk factors include passive smoking, genetic predisposition, air pollution, and occupational exposure to radiation or harmful substances.

How to Prevent Lung Cancer?

The first and most effective step is not to start smoking—or quitting if already started. Encouragingly, the risk of developing lung cancer significantly decreases within seven years after quitting. Regular exercise, a healthy diet, and overall lifestyle improvements further reduce cancer risks. But quitting smoking remains essential!

Innovative solutions in lung cancer treatment! Easily access Cuba’s immunotherapy and innovative treatment methods with QBA Medi Tours. Manage your process safely with our expert team. Contact us now and discover the best treatment options!

What are the Types of Lung Cancer?

We took a quick look at the risk factors in lung cancer and how the disease occurs. But we have always named it with a single term, but aren’t there types of this disease? Of course there are. The disease is divided into two types: small cell and non-small cell lung cancer, the latter, NSCLC, accounts for about 85 percent of lung cancer cases. There are also subtypes of non-small cell lung cancer, which are divided into three:
Adenocarcinoma, the most common subtype of the most common type
Squamous cell carcinoma most commonly associated with smoking
And large cell carcinoma, which can be more aggressive than these other two types.

All these details, and of course the stage of the cancer, serve as parameters in determining treatment methods. So it is also useful to understand the stages.

How is Lung Cancer Treated?

Treatment options vary depending on the stage of the disease and the patient’s general health status.

When non-small cell lung cancer (NSCLC) is diagnosed at an early stage, surgical treatment is considered the best option. In Stage I and some Stage II patients, lobectomy or pneumonectomy can be performed to completely remove the tumor. If the disease has spread to the lymph nodes, adjuvant chemotherapy is recommended after surgery. For inoperable early-stage patients, precise radiation treatments such as stereotactic body radiotherapy (SBRT) can be applied. In stage III patients, a combination of chemotherapy and radiotherapy is preferred. In some selected patients, surgery may be considered after chemotherapy and radiotherapy. After treatment, additional chemotherapy can be administered to eliminate micro metastases and prevent recurrence of the disease.

In stage IV, metastatic NSCLC, treatment is completely shaped according to the spread of the disease and the genetic structure of the tumor. Platinum-based combination chemotherapies stand out as the most commonly used treatment method. Targeted therapies have also gained great importance in recent years. For example, drugs such as Erlotinib or Gefitinib are used in patients with EGFR mutation, while Crizotinib is preferred for patients with ALK gene mutation. Anti-angiogenic therapies such as Bevacizumab aim to stop the growth of the tumor by preventing the formation of blood vessels. In patients with advanced disease who respond to chemotherapy, maintenance therapy is used to prolong life.

Chemotherapy and radiotherapy are considered the main methods in the treatment of small cell lung cancer (SCLC). In limited stage SCLC patients, chemotherapy with a combination of Etoposide and Cisplatin is administered, while radiotherapy can be given at the same time. At this stage, radiotherapy called prophylactic cranial irradiation (PCI) can also be applied to prevent brain metastases. Although surgical treatment is generally not preferred for SCLC, it can be supported with adjuvant chemotherapy after surgery in some Stage I patients.

In patients with diffuse stage SCLC, treatment starts with platinum-based chemotherapy and is usually administered for 4-6 cycles. Since the risk of brain metastasis is high, some patients may undergo preventive brain irradiation. Radiotherapy is mostly used to alleviate symptoms. Since small cell lung cancer is a type of cancer that usually spreads rapidly, second-line chemotherapy options come into play if the disease recurs. Drugs such as Topotecan and Amrubicin are among the main treatment agents used in recurrent diseases.

As a result, while surgery is at the forefront of NSCLC treatment in the early stages, chemotherapy, radiotherapy and targeted therapies come into play in advanced patients. Since SCLC is a more aggressive disease, it is mainly treated with chemotherapy and radiotherapy. In metastatic cases, palliative approaches also play an important role to improve the patient’s quality of life.

Innovative solutions in lung cancer treatment! Easily access Cuba’s immunotherapy and innovative treatment methods with QBA Medi Tours. Manage your process safely with our expert team. Contact us now and discover the best treatment options!

What is Cuba Lung Cancer Treatment?

Cuba is a country that attracts worldwide attention with the immunotherapeutic vaccines it has developed in the treatment of lung cancer. Innovative vaccines such as CIMAvax-EGF and Racotumomab (Vaxira) aim to prevent cancer cells from multiplying by strengthening the immune system. These vaccines are administered as complementary therapy, especially for patients with non-small cell lung cancer (NSCLC). CIMAvax targets epidermal growth factor (EGF), which triggers tumor growth, while Vaxira stimulates the immune system to create a natural defense mechanism against cancer cells.

These treatment approaches in Cuba are complementary methods that aim to prolong life and improve the quality of life of patients. However, since each patient’s health condition is different, a specialist doctor’s assessment is required to determine the suitability of treatment. These methods, developed through scientific research in Cuba, offer promising options in the fight against lung cancer.

How to Access Cuba Lung Cancer Treatment?

For patients wishing to benefit from lung cancer treatment in Cuba, QBA Medi Tours is a trusted medical tourism consultant that organizes the entire process. A specific application process is followed to access the CIMAvax-EGF and Racotumomab (Vaxira) vaccines developed by Cuba:

• Evaluation of your medical file: First, patient reports and medical history are prepared and submitted by the QBA Medi Tours team of experts for review by the Cuban Ministry of Health.
• Confirmation of treatment eligibility: The patient’s file is evaluated by specialized doctors in Cuba and a response is received within 7-10 working days on whether the patient is eligible for treatment.
• Treatment planning: Upon approval, QBA Medi Tours organizes transportation, accommodation and treatment program. Patients are supported at every stage, including airport transfers, hospital appointments and interpretation services.Contact us to start your wellness journey to Cuba.